Jin Medical International (ZJYL) - Bathi resik saben saham (EPS TTM)

Jin Medical International (ZJYL) develops high-tech wheelchairs by integrating robotics and IoT solutions. However, logistical complexities in the PRC and pricing pressure from regulators create risks for margins. The company's annual net profit per share on GURU.Markets reflects revenue dynamics, where the 0.15 level captures the current state. Stable operating leverage and assembly automation enable efficient export scaling, maintaining total profit at a mature plateau.
ZJYL (Jin Medical International Ltd): rincian analitis lan laporan miturut indikator

Jin Medical International (ZJYL) is integrating ESG principles by modernizing wheelchair production through the use of recyclable lightweight alloys. These capital expenditures directly impact net income, which is divided by the total number of shares. This metric measures the real business return over the last four quarters after deducting all expenses. By analyzing the rolling 12-month earnings per share, an investor assesses the viability of the model. The stability of this chart confirms the enterprise's financial resilience.